Work

Chimeric Antigen Receptor (CARs) for Thymidine Kinase 1 (TK1): A novel immunotherapy approach to fight cancer.

Year: 2017

Type: article

Authors: Edwin J. Velazquez, Kiara Vaden, Michelle H. Townsend, Evita G. Weagel, Scott Weber, Richard A. Robison, Kim L. O’Neill

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603394877

FWCI:

Cites:

Cited by:

Related to: 10